AV078

DRUG2 trials

Sponsors

Aeovian Pharmaceuticals, Inc.

Conditions

EpilepsyHealthy ParticipantsTuberous Sclerosis Complex

Phase 1

Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy Volunteers

CompletedNCT06205381

Aeovian Pharmaceuticals, Inc.Healthy Participants

Start: 2024-01-31End: 2025-02-08Updated: 2025-03-26

Phase 2

A Phase 2 Study of the Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy

Not yet recruitingNCT07680322

Aeovian Pharmaceuticals, Inc.Epilepsy, Tuberous Sclerosis Complex

Start: 2026-09-01End: 2027-12-21Target: 42Updated: 2026-07-02